H. pylori—testing and treatment consensus
BreathTek UBT aligns with guideline recommendations from ACG, AAFP, and Maastricht V/Florence Consensus Report to test for H. pylori in patients with uninvestigated dyspepsia.1-3
Abbreviations: ACG, American College of Gastroenterology; AAFP, American Academy of Family Physicians.
ACG guidelines recommend a test-and-treat strategy and also recommend to confirm eradication testing of H. pylori infection using UBT, fecal antigen test, and endoscopy methods.
- Test to detect the underlying cause of the condition
- Treat the patient if infection is detected
- Test again to confirm eradication at least 4 weeks after completing treatment
H. pylori testing should be performed by a test of active infection, such as 13C-urea breath test or stool antigen test (non-endoscopic tests).4
The test-and-treat strategy is recommended for patients who are under the age of 60 years and have no "alarm features."
- Alarm features include bleeding, anemia, early satiety, unexplained weight loss, progressive dysphagia, odynophagia, recurrent vomiting, family history of GI cancer, and previous esophagogastric malignancy2